Issue of Equity and Total Voting Rights
Summary by AI BETAClose X
Bridgepoint Group plc
("Bridgepoint" or the "Company")
Issue of Equity and Total Voting Rights
Bridgepoint announces that it intends to issue 1,399,733 ordinary shares of £0.00005 each ("New Ordinary Shares") to satisfy vesting awards granted in prior years under Bridgepoint's Long Term Incentive Plan. The New Ordinary Shares will rank pari passu with existing ordinary shares in issue.
An application has been made for the admission of the New Ordinary Shares to trading on the LSE's main market for listed securities.
Admission is expected to occur on 26 March 2026.
In conformity with the Financial Conduct Authority's Disclosure and Transparency Rules, Bridgepoint announces that its total issued share capital following the issue of the New Ordinary Shares will comprise:
|
• |
878,071,547 ordinary shares of £0.00005 each with voting rights; and |
|
• |
500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred share of £0.01, each with no voting rights. |
Bridgepoint holds no shares in treasury. Following the issue of the New Ordinary Shares the total number of voting rights in the Company will therefore be 878,071,547, and this figure may be used by shareholders at such time as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Bridgepoint under the Disclosure Guidance and Transparency Rules.
ENQUIRIES
Bridgepoint
|
Analysts and investors Adam Key Adam.Key@bridgepointgroup.com
|
Media Christian Jones Christian.Jones@bridgepointgroup.com +44 20 7034 3500 |
FGS Global (Public Relations Adviser to Bridgepoint)
James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911
Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233
Issued by Bridgepoint Group plc
LEI: 213800KFNMVI8PDZX472
Registered in England and Wales no. 11443992
Registered office: 5 Marble Arch, London, W1H 7EJ
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 16 minutes ago Savills
- 36 minutes ago Everyman Media Group
- 1 hour ago Croda International
- 2 hours ago Diageo
- 2 hours ago IMI